उत्पाद विवरण
Bevarest 400 mg injection is a vital therapeutic option in the fight against various cancers, effectively utilized in combination with other treatments to manage conditions such as colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This innovative medication features bevacizumab, a monoclonal antibody designed to inhibit the activity of vascular endothelial growth factor (VEGF), a protein that promotes tumor blood vessel growth. By blocking VEGF, Bevarest helps to starve tumors of the oxygen and nutrients they need to grow, thereby slowing cancer progression. Patients considering this treatment should be aware of potential side effects, including increased risk of bleeding, hypertension, and gastrointestinal perforations, necessitating careful monitoring by healthcare providers. Before starting treatment, its essential to discuss any pre-existing conditions or medications with your doctor to ensure safe use. Administered via injection, Bevarest is often part of a comprehensive cancer management plan tailored to individual patient needs. This powerful injection exemplifies the ongoing advancements in oncology, providing hope for patients battling challenging cancers. With continued research and clinical studies, Bevarest remains an important tool in improving patient outcomes and enhancing quality of life for those affected by cancer.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese